Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids.

In situ hybridization was used to localize and quantify gene expression in rheumatoid arthritis (RA) and osteoarthritis (OA) synovial tissue. Collagenase, tissue inhibitor of metalloproteinases (TIMP), HLA-DR, and complement (C2 and C3) gene expression was studied in synovial tissue from 23 patients with RA, OA, or other inflammatory arthropathies. Gene expression was highly compartmentalized: Collagenase, TIMP, and C2 messenger RNA (mRNA) were localized primarily to the synovial lining layer; HLA-DR mRNA was prominent in the lining and in some sublining lymphoid aggregates; the C3 probe hybridized only to sublining lymphoid aggregates. Relative mRNA levels were quantified using computer-assisted image analysis. There was significantly more collagenase, C2, C3, and HLA-DR mRNA in RA compared with OA patients. However, TIMP mRNA levels were similar in RA and OA. Expression of collagenase, TIMP, C2, C3, and HLA-DR genes correlated with the degree of synovial inflammation. The effect of intraarticular corticosteroid injection on synovial tissue gene expression was studied using serial percutaneous synovial biopsy samples from the knees of 3 RA patients. Joints were biopsied, injected with triamcinolone, and rebiopsied 1-2 weeks later. Histologic inflammation scores were lower in posttreatment synovia. Collagenase and TIMP mRNA, although abundant in presteroid samples, were nearly undetectable in post-steroid tissues. HLA-DR mRNA levels also were significantly decreased. C2 and C3 hybridization significantly decreased in 2 of 3 patients and 1 of 3 patients, respectively. Hence, clinical response to intraarticular steroid therapy was accompanied by histologic improvement and decreased expression of genes that play a role in articular destruction.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  Complement biosynthesis in human synovial tissue. , 1989, Clinical and experimental immunology.

[2]  D. Larhammar,et al.  Signal Sequences Distinguish Class II Histocompatibility Antigen ß Chains of Different Loci , 1984, Scandinavian journal of immunology.

[3]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[4]  H. Colten,et al.  Regulation of class III major histocompatibility complex gene products by interleukin-1. , 1986, Science.

[5]  R. Strunk,et al.  IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. , 1989, Journal of immunology.

[6]  R. Strunk,et al.  Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. , 1985, The Journal of clinical investigation.

[7]  B. Bresnihan,et al.  Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[8]  M. Karin,et al.  Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.

[9]  J. Case,et al.  Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. , 1989, The American journal of pathology.

[10]  B. Littman,et al.  Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-gamma. , 1989, Journal of immunology.

[11]  H. Colten,et al.  Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. , 1984, The Journal of clinical investigation.

[12]  R. Winchester,et al.  Differential expression of Ia antigens by rheumatoid synovial lining cells. , 1987, The Journal of clinical investigation.

[13]  R. Deschenes,et al.  A gene encoding rat cholecystokinin. Isolation, nucleotide sequence, and promoter activity. , 1985, The Journal of biological chemistry.

[14]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. , 1990, The Journal of clinical investigation.

[15]  G. Firestein,et al.  Quantitative molecular hybridization with unfractionated, solubilized cells using RNA probes and polyacrylamide gel electrophoresis. , 1987, Analytical biochemistry.

[16]  N. Oppenheimer-Marks,et al.  Pathways to chronic inflammation in rheumatoid synovitis. , 1987, Federation proceedings.

[17]  H. Colten,et al.  gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. , 1985, The Journal of biological chemistry.

[18]  E. Brown,et al.  Molecular characterization and expression of the gene encoding human erythroid-potentiating activity , 1985, Nature.

[19]  R. Maki,et al.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.

[20]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis , 1989, The Journal of experimental medicine.

[21]  T. Hirano,et al.  Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins , 1988 .